Author

Hong Hu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Final Analysis of the Neotorch Study: Perioperative Toripalimab in Combination with Chemotherapy for Patients with Stage Ⅱ/Ⅲ Resectable Non-Small Cell Lung Cancer.

BACKGROUND Interim analysis of the Neotorch study demonstrated significant benefit in event-free survival (EFS) and major pathological response (MPR) rate for perioperative toripalimab plus chemotherapy in patients with resectable Stage Ⅲ non-small cell lung cancer (NSCLC). Here, we report the final analysis results of...

Zi-Ming Li, L. Wu, W.-X. Wang et al. · Annals of Oncology · 0 citations

Open access Sep 2026

Distinct Molecular Landscape and Clinical Subtype of HPV-Positive Esophageal Squamous Cell Carcinoma

Simple Summary Human papillomavirus (HPV) is a well-established cause of several anogenital and oropharyngeal cancers, but its role in esophageal squamous cell carcinoma (ESCC) among Chinese patients remains controversial. We retrospectively analyzed 120 Chinese patients with ESCC and detected HPV DNA in 44.2% of tumor...

Hang Li, Xu-Xia Shen, Yan Jin et al. · Cancers · 0 citations